Cargando…
Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study
OBJECTIVES: The aim of the SIMPACT study was to evaluate the efficacy and safety of MTX-free s.c. tocilizumab (TCZ) therapy in RA patients. METHODS: SIMPACT was an open-label, non-controlled, non-randomized, non-interventional study, in which RA patients for whom the treating physicians ordered s.c....
Autores principales: | Nagy, György, Géher, Pál, Tamási, László, Drescher, Edit, Keszthelyi, Péter, Pulai, Judit, Czirják, László, Szekanecz, Zoltán, Kiss, Gergely, Kovács, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154320/ https://www.ncbi.nlm.nih.gov/pubmed/35663154 http://dx.doi.org/10.1093/rap/rkac038 |
Ejemplares similares
-
Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients
por: Végh, Edit, et al.
Publicado: (2021) -
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
por: Baji, Petra, et al.
Publicado: (2014) -
Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin
por: Kovács, Edina, et al.
Publicado: (2017) -
Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis
por: Oláh, Csaba, et al.
Publicado: (2017) -
One Step Back from Bedside to the Bench—How Do Different Arterial Stiffness Parameters Behave in Relation to Peripheral Resistance?
por: Obajed Al-Ali, Nóra, et al.
Publicado: (2023)